Main Content
;
With a very heavy heart, we announce the passing of our CEO and co-founder, Susan Solomon, following a long battle with ovarian cancer. We owe all that NYSCF has accomplished to Susan, and no words can express our gratitude and awe for her catalytic impact on stem cell research.
Great panel on regulatory futures for CGT from various perspectives - Niloofar Davoodi, @TakedaPharma, Ian Rees, @MHRAgovuk, Michael von Forstner, @biogen and led by Jacqueline Barry, @CGTCatapult
#advancedtherapieseurope #ate2022 #ate22 #celltherapy #regulatory
Companies developing iPSC-based cell therapies
Characterization of advanced therapies: leveraging advanced #analytics to avoid #FDA holds
Find out the key #assay types needed for successful characterization of #cellandgenetherapy
Read the FastFacts poster, or watch the video, here: http://bit.ly/3AxQmMz
#celltherapy
https://advancedtherapiesweek.phacilitate.com/
GAiT looks forward to speaking to Indian Colleagues from CMC Vellore at the 7th Cell and Gene Therapy Symposium 1st -3rd September 2022. http://www.cscr.res.in/symposium
